Drug Type Small molecule drug |
Synonyms Alpha lipoic acid/losartan, Losartan/alpha lipoic acid, Losartan/thioctic acid + [2] |
Target |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H14O2S2 |
InChIKeyAGBQKNBQESQNJD-SSDOTTSWSA-N |
CAS Registry1200-22-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Jun 2011 | |
Hypertension | Phase 2 | US | 01 Jun 2011 | |
Kidney Diseases | Phase 2 | US | 01 Jun 2011 |